Ontology highlight
ABSTRACT: Background
Mastocytosis associated with germline KIT activating mutations is exceedingly rare. We report the unique clinicopathologic features of a patient with systemic mastocytosis caused by a de novo germline KIT K509I mutation.Objectives
We sought to investigate the effect of the germline KIT K509I mutation on human mast cell development and function.Methods
Primary human mast cells derived from CD34(+) peripheral blood progenitors were examined for growth, development, survival, and IgE-mediated activation. In addition, a mast cell transduction system that stably expressed the KIT K509I mutation was established.Results
KIT K509I biopsied mast cells were round, CD25(-), and well differentiated. KIT K509I progenitors cultured in stem cell factor (SCF) dem
SUBMITTER: Chan EC
PROVIDER: S-EPMC4125511 | biostudies-literature | 2014 Jul
REPOSITORIES: biostudies-literature